Home World News EMA Recommends Granting a Marketing Authorisation for Nirogacestat World News EMA Recommends Granting a Marketing Authorisation for Nirogacestat By Ogkologos - July 3, 2025 380 0 Facebook Twitter Google+ Pinterest WhatsApp It is intended for the treatment of adult patients with progressing desmoid tumours Source RELATED ARTICLESMORE FROM AUTHOR Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR Long-Term Outcomes in Patients with Metastatic Melanoma Treated with Anti-PD1 Therapy... October 28, 2021 Delayed irAEs Occur in a Small Subset of Patients with Melanoma,... April 1, 2021 Pediatricians’ Offices Can Help Parents Quit Smoking, Study Shows September 12, 2019 Can Targeted Therapy for KRAS Mutations Double as Part of Immunotherapy? October 31, 2022 Load more HOT NEWS Misdiagnosis: Her Doctor Dismissed Her Concerns For Months Then Told Her... Data from a Large Cohort of Patients with mRCC Demonstrate the... Should People with Cancer and Cancer Survivors Get the Flu Vaccine? Cancer Research UK publishes gender and ethnicity pay gap reports
